Special Topics

ATTC National Treatment Workforce Study 2017ATTC National Treatment Workforce Study 2017 In 2017, the ATTC Network Coordinating Office (NCO) worked with the Regional and National Focus Area Centers (NFA) to develop and implement a nationwide qualitative workforce study as a follow-up to the 2012 study, Vital Signs: Taking the Pulse of the Addiction Treatment Workforce (see Ryan, Murphy, & Krom, 2012). The study report (2017) offers a national perspective on current recruitment and retention strategies being used to build the workforce guide development of training/technical assistance resources that address emerging trends in the field.

In 2017, the ATTC Network Coordinating Office (NCO) worked with the Regional and National Focus Area Centers (NFA) to develop and implement a nationwide qualitative workforce study as a follow-up to the 2012 study, Vital Signs: Taking the Pulse of the Addiction Treatment Workforce (see Ryan, Murphy, & Krom, 2012). The study report (2017) offers a national perspective on current recruitment and retention strategies being used to build the workforce guide development of training/technical assistance resources that address emerging trends in the field.
NATIONAL WORKFORCE REPORT 2017: Strategies for Recruitment, Retention, and Development of the substance Use Disorder Treatment and Recovery Services Workforce: A National Qualitative Report September 2017


SAMHSA's TIP 63 Medications for Opioid Use Disorder

SAMHSA’s TIP 63 Medications for Opioid Use Disorder TIP 63 reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat opioid use disorder (OUD)—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. Read more about it in the ATTC/NIATx Service Improvement Blog (link to http://attcniatx.blogspot.com/).

TIP 63 reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat opioid use disorder (OUD)—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD.

 

Read more about it in the ATTC/NIATx Service Improvement Blog.

 

 



2017 National Cannabis Summit: Summary of Proceedings

The three day 2017 National Cannabis Summit took place in Denver, CO August 2017 with 473 participants in attendance. The program featured 57 presentations focused on emerging research and epidemiological data, law and policy, prevention, public health and safety, and the science of cannabis. Prepared in collaboration by the ATTC Network, Advocates for Human Potential, Inc., and the National Council for Behavioral Health, the 2017 National Cannabis Summit: Summary of Proceedings was released February 2018 and provides an overview of central takeaway points and lessons learned during the Summit. The report is divided into three sections:  The state of the science concerning the impact of cannabis on health, well-being, and safety Issues related to policy, regulation, and strategies for promoting public health as cannabis laws evolve Steps researchers and policymakers can take to advance cannabis science and public health policy in the age of legalization To download a free copy click Summary of Proceedings.

The three day 2017 National Cannabis Summit took place in Denver, CO August 2017 with 473 participants in attendance. The program featured 57 presentations focused on emerging research and epidemiological data, law and policy, prevention, public health and safety, and the science of cannabis. Prepared in collaboration by the ATTC Network, Advocates for Human Potential, Inc., and the National Council for Behavioral Health, the 2017 National Cannabis Summit: Summary of Proceedings was released February 2018 and provides an overview of central takeaway points and lessons learned during the Summit. 

The report is divided into three sections:

  • The state of the science concerning the impact of cannabis on health, well-being, and safety
  • Issues related to policy, regulation, and strategies for promoting public health as cannabis laws evolve
  • Steps researchers and policymakers can take to advance cannabis science and public health policy in the age of legalization

To download a free copy click Summary of Proceedings